Anhedonia in the psychosis risk syndrome: Associations with social impairment and basal orbitofrontal cortical activity

npj Schizophrenia

Volumn 1, Issue 1, 2015, Pages

  Cressman, Victoria L ^a,c   Schobel, Scott A ^a,d   Steinfeld, Sara ^b   Ben David, Shelly ^b,e   Thompson, Judy L ^a,f   Small, Scott A ^a   Moore, Holly ^a,b   Corcoran, Cheryl M ^a,b  

^a Columbia University College of Physicians ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e NEW YORK UNIVERSITY   (United States)

^f State University of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANHEDONIA; ARTICLE; ASSESSMENT OF HUMANS; BASAL FOREBRAIN; BASAL METABOLIC RATE; BRAIN BLOOD VOLUME; BRAIN REGION; CHAPMAN REVISED ANHEDONIA SCALE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ORBITAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; REWARD; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL ADJUSTMENT SELF REPORT SCALE; SOCIAL ANXIETY SCALE FOR ADOLESCENT; SOCIAL PHOBIA;

EID: 85016776443     PISSN: None     EISSN: 2334265X     Source Type: Journal    
DOI: 10.1038/npjschz.2015.20     Document Type: Article

References (62)

1. Morrison RL, Bellack AS. Social functioning of schizophrenic patients: clinical and research issues. Schizophr Bull 1987; 13: 715-725.
2. Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA et al. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry 2007; 164: 428-436.
3. Roberts DL, Velligan DI. Can social functioning in schizophrenia be improved through targeted social cognitive intervention? Rehabil Res Pract 2012; 2012: 742106-742136.
4. Bearden CE, Rosso IM, Hollister JM, Sanchez LE, Hadley T, Cannon TD. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia. Schizophr Bull 2000; 26: 395-410.
5. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994; 344: 1398-1402.
6. Hafner H, Loffler W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999; 100: 105-118.
7. Carrion RE, McLaughlin D, Goldberg TE, Auther AM, Olsen RH, Olvet DM et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry 2013; 70: 1133-1142.
8. Ballon JS, Kaur T, Marks II, Cadenhead KS. Social functioning in young people at risk for schizophrenia. Psychiatry Res 2007; 151: 29-35.
9. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99: 119-124.
10. Corcoran CM, Kimhy D, Parrilla-Escobar MA, Cressman VL, Stanford AD, Thompson J et al. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med 2011; 41: 251-261.
11. Blanchard JJ, Horan WP, Brown SA. Diagnostic differences in social anhedonia: a longitudinal study of schizophrenia and major depressive disorder. J Abnorm Psychol 2001; 110: 363-371.
12. Meehl PE. Primary and secondary hypohedonia. J Abnorm Psychol 2001; 110: 188-193.
13. Horan WP, Blanchard JJ, Clark LA, Green MF. Affective traits in schizophrenia and schizotypy. Schizophr Bull 2008; 34: 856-874.
14. Blanchard JJ, Mueser KT, Bellack AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull 1998; 24: 413-424.
15. Herbener ES, Harrow M. The course of anhedonia during 10 years of schizophrenic illness. J Abnorm Psychol 2002; 111: 237-248.
16. Cohen AS, Dinzeo TJ, Nienow TM, Smith DA, Singer B, Docherty NM. Diminished emotionality and social functioning in schizophrenia. J Nerv Ment Dis 2005; 193: 796-802.
17. Niendam TA, Bearden CE, Zinberg J, Johnson JK, O'Brien M, Cannon TD. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull 2007; 33: 772-781.
18. Kwapil TR. Social anhedonia as a predictor of the development of schizophreniaspectrum disorders. J Abnorm psychol 1998; 107: 558-565.
19. Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. J Abnorm psychol 2004; 161: 53-58.
20. Burbridge JA, Barch DM. Anhedonia and the experience of emotion in individuals with schizophrenia. J Abnorm Psychol 2007; 116: 30-42.
21. Penn DL, Hope DA, Spaulding W, Kucera J. Social anxiety in schizophrenia. Schizophr Res 1994; 11: 277-284.
22. Voges M, Addington J. The association between social anxiety and social functioning in first episode psychosis. Schizophr Res 2005; 76: 287-292.
23. Michail M, Birchwood M. Social anxiety disorder in first-episode psychosis: incidence, phenomenology and relationship with paranoia. Br J Psychiatry 2009; 195: 234-241.
24. Rietdijk J, Ising HK, Dragt S, Klaassen R, Nieman D, Wunderink L et al. Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis. Psychiatry Res 2013; 209: 309-313.
25. Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol 1976; 85: 374-382.
26. Mishlove M, Chapman LJ. Social anhedonia in the prediction of psychosis proneness. J Abnorm Psychol 1985; 94: 384-396.
27. Blanchard JJ, Collins LM, Aghevli M, Leung WW, Cohen AS. Social anhedonia and schizotypy in a community sample: the Maryland longitudinal study of schizotypy. Schizophr Bull 2011; 37: 587-602.
28. Gooding DC, Tallent KA, Matts CW. Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy. J Abnorm Psychol 2005; 114: 170-175.
29. Bray S, Shimojo S, O'Doherty JP. Human medial orbitofrontal cortex is recruited during experience of imagined and real rewards. J Neurophysiol 2010; 103: 2506-2512.
30. Harvey PO, Armony J, Malla A, Lepage M. Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. J Psychiatr Res 2010; 44: 707-716.
31. Kang MJ, Rangel A, Camus M, Camerer CF. Hypothetical and real choice differentially activate common valuation areas. J Neurosci 2011; 31: 461-468.
32. Fareri DS, Martin LN, Delgado MR. Reward-related processing in the human brain: developmental considerations. Dev Psychopathol 2008; 20: 1191-1211.
33. Ernst M, Pine DS, Hardin M. Triadic model of the neurobiology of motivated behavior in adolescence. Psychol Med 2006; 36: 299-312.
34. Liberzon I, Phan KL, Decker LR, Taylor SF. Extended amygdala and emotional salience: a PET activation study of positive and negative affect. Neuropsychopharmacology 2003; 28: 726-733.
35. Walter H, Abler B, Ciaramidaro A, Erk S. Motivating forces of human actions. Neuroimaging reward and social interaction. Brain Res Bull 2005; 67: 368-381.
36. Knutson B, Cooper JC. Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 2005; 18: 411-417.
37. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703-715.
38. Hawkins KA, McGlashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB et al. Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res 2004; 68: 339-347.
39. Taylor MJ, Heaton RK. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc 2001; 7: 867-874.
40. Nurnberger JI Jr., Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51: 849-859.
41. Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 1978; 166: 317-326.
42. McCreadie RG, Barron ET. The Nithsdale schizophrenia survey. IV. Social adjustment by self-report. Br J Psychiatry 1984; 144: 547-550.
43. Herbener ES, Harrow M, Hill SK. Change in the relationship between anhedonia and functional deficits over a 20-year period in individuals with schizophrenia. Schizophr Res 2005; 75: 97-105.
44. Eckblad M, Chapman LJ, Chapman JP, Mishlove M. The Revised Social Anhedonia ScaleUnpublished test University of Wisconsin: Madison, WI, USAMadison, WI, USA, 1982.
45. Kwapil TR, Barrantes-Vidal N, Silvia PJ. The dimensional structure of the wisconsin schizotypy scales: factor identification and construct validity. Schizophr Bull 2008; 34: 444-457.
46. La Greca AM, Lopez N. Social anxiety among adolescents: linkages with peer relations and friendships. J Abnorm Child Psychol 1998; 26: 83-94.
47. Inderbitzen-Nolan HM, Walters KS. Social Anxiety Scale for Adolescents: normative data and further evidence of construct validity. J Clin Child Psychol 2000; 29: 360-371.
48. Storch EA, Masia-Warner C, Dent HC, Roberti JW, Fisher PH. Psychometric evaluation of the Social Anxiety Scale for Adolescents and the Social Phobia and Anxiety Inventory for Children: construct validity and normative data. J Anxiety Disord 2004; 18: 665-679.
49. Schobel Scott A, Chaudhury Nashid H, Khan Usman A, Paniagua B, Styner Martin A, Asllani I et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 2013; 78: 81-93.
50. Dowd EC, Barch DM. Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia. PLoS One 2012; 7: e35622.
51. Padoa-Schioppa C. Orbitofrontal cortex and the computation of economic value. Ann N Y Acad Sci 2007; 1121: 232-253.
52. Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry 2013; 74: 130-136.
53. Wolf DH, Satterthwaite TD, Kantrowitz JJ, Katchmar N, Vandekar L, Elliott MA et al. Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull 2014; 40: 1328-1337.
54. Waltz JA, Schweitzer JB, Ross TJ, Kurup PK, Salmeron BJ, Rose EJ et al. Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology 2010; 35: 2427-2439.
55. Heimer L, Van Hoesen GW. The limbic lobe and its output channels: implications for emotional functions and adaptive behavior. Neurosci Biobehav Rev 2006; 30: 126-147.
56. Wang Y, Deng Y, Fung G, Liu WH, Wei XH, Jiang XQ et al. Distinct structural neural patterns of trait physical and social anhedonia: evidence from cortical thickness, subcortical volumes and inter-regional correlations. Psychiatry Res 2014; 224: 184-191.
57. Dodell-Feder D, Tully LM, Lincoln SH, Hooker CI. The neural basis of theory of mind and its relationship to social functioning and social anhedonia in individuals with schizophrenia. NeuroImage Clin 2014; 4: 154-163.
58. Reise SP, Horan WP, Blanchard JJ. The challenges of fitting an item response theory model to the Social Anhedonia Scale. J Pers Assess 2011; 93: 213-224.
59. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
60. Cornblatt BA, Carrion RE, Addington J, Seidman L, Walker EF, Cannon TD et al. Risk factors for psychosis: impaired social and role functioning. Schizophr Bull 2012; 38: 1247-1257.
61. Hafner H, Maurer K, Loffler W, an der Heiden W, Hambrecht M, Schultze-Lutter F. Modeling the early course of schizophrenia. Schizophr Bull 2003; 29: 325-340.
62. Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS et al. Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci 2012; 32: 6170-6176.